CAMBRIDGE, Mass., Oct. 31 /PRNewswire-FirstCall/ -- Vertex
Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it will
webcast its presentations at three upcoming investor conferences:
* MASS Opportunities: A Biotechnology Investment Conference (Boston, MA)
on Thursday, November 2, 2006 at 2:50 p.m. EST, presented by Michael
Partridge, Director, Corporate Communications of Vertex.
* Cowen & Co. 7th Annual Global Health Care Conference (London, UK) on
Tuesday, November 7, 2006 at 10:00 a.m. GMT (5:00 a.m. EST), presented
by Joshua Boger, Ph.D., President and Chief Executive Officer of Vertex.
* ThinkEquity Partners ThinkTank (New York, NY) on Friday, November 10,
2006 at 9:40 a.m. EST, presented by John Alam, M.D., Executive Vice
President, Medicines Development and Chief Medical Officer of Vertex.
Each presentation will be webcast live and may be accessed by visiting
the Vertex website at http://www.vrtx.com. A replay of the webcasts will
also be available on the Company's website for two weeks following the
presentations. To access the webcasts, go to Vertex's website and select
the desired presentation from the 'Events & Presentations' page. To ensure
a timely connection, it is recommended that users register at least 15
minutes prior to the scheduled webcast.
About Vertex
Vertex Pharmaceuticals Incorporated is a global biotechnology company
committed to the discovery and development of breakthrough small molecule
drugs for serious diseases. The Company's strategy is to commercialize its
products both independently and in collaboration with major pharmaceutical
companies. Vertex's product pipeline is focused on viral diseases,
inflammation, autoimmune diseases, cancer, pain and bacterial infection.
Vertex co-discovered the HIV protease inhibitor, Lexiva, with
GlaxoSmithKline.
Lexiva is a registered trademark of the GlaxoSmithKline group of
companies.
Vertex's press releases are available at http://www.vrtx.com.
Vertex Contact:
Lora Pike, Manager, Investor Relations, (617) 444-6755
SOURCE Vertex Pharmaceuticals Incorporated
 back to top
Related links:
http://www.vrtx.com
http://www.prnewswire.com/comp/938395.html/
CONTACT:
Lora Pike, Manager, Investor Relations for
Vertex, +1-617-444-6755
|
